ACROBiosystems

ACROBiosystems

Foundation date

2010

Sector

#Biotechnology - other

Subsector

• #Therapeutics - Cell therapy
• #Therapeutics - Gene therapy
• #Therapeutics - Proteins
• #Therapeutics - Stem cells
• #Therapeutics - Vaccines
• #R&D Services - Analytical services
• #R&D Services - Screening
• #Therapeutics - Antibodies

Therapeutic areas

• #Diseases of the nervous system
• #Infectious and parasitic diseases
• #Neoplasms / cancer / oncology

ACROBiosystems is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.

ACROBiosystems’ main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.

Through the continuous development of new technologies and products, ACROBiosystems creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.